ARCHIVES

Blincyto Demonstrates Response In Minimal Residual Disease ALL

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002

NCI Seeks Health Care Provider Groups To Form Cancer Control Research Network

September 12, 1997

DCT Board Insists On Being Heard In Development Of CCOP Guidelines

February 19, 1982

ASTRO Members Approve Governance, Dues Changes

January 17, 2003

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

March 25, 2011

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979